Published in J Neurol Sci on November 28, 2008
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation (2012) 3.12
Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol (2009) 2.16
B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol (2012) 1.80
Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol (2014) 1.38
The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS One (2010) 1.32
IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One (2009) 1.25
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation (2016) 1.20
Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs' heterochromic cyclitis. Graefes Arch Clin Exp Ophthalmol (2010) 1.11
Measles IgG antibody index correlates with T2 lesion load on MRI in patients with early multiple sclerosis. PLoS One (2012) 0.92
The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort. Fluids Barriers CNS (2015) 0.86
Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis. PLoS One (2012) 0.79
The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature. J Neurol (2016) 0.76
High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients. Mol Cell Proteomics (2016) 0.75
The MRZ reaction in primary progressive multiple sclerosis. Fluids Barriers CNS (2017) 0.75
Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy. J Neuroinflammation (2016) 0.75
Periventricular white matter lesion and incomplete MRZ reaction in a male patient with anti-N-methyl-D-aspartate receptor encephalitis presenting with dysphoric mania. BMJ Case Rep (2015) 0.75
Opsoclonus-myoclonus syndrome after adenovirus infection. Springerplus (2015) 0.75
CSF profile in primary progressive multiple sclerosis: Re-exploring the basics. PLoS One (2017) 0.75
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol (2010) 3.28
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation (2012) 3.12
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol (2008) 2.40
Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol (2005) 2.28
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients. Neurology (2013) 2.02
Palliative Care of Adult Patients With Cancer. Dtsch Arztebl Int (2015) 2.02
Drug interactions in dying patients: a retrospective analysis of hospice inpatients in Germany. Drug Saf (2012) 2.00
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol (2013) 1.79
Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol (2007) 1.74
Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol (2013) 1.69
Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid. Crit Care Med (2012) 1.67
Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol (2013) 1.63
Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells. Arch Neurol (2008) 1.62
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation (2010) 1.60
In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J Immunol (2005) 1.58
T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients. Neurology (2013) 1.51
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci (2010) 1.45
Fentanyl for the relief of refractory breathlessness: a systematic review. J Pain Symptom Manage (2013) 1.44
High dose levo-methadone treatment for cancer pain in a patient with a history of drug addiction. J Pain Symptom Manage (2008) 1.41
Cross-reactive T-cell receptors in tumor and paraneoplastic target tissue. Arch Neurol (2009) 1.40
Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol (2004) 1.40
Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J Immunol (2003) 1.29
Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma". J Dtsch Dermatol Ges (2013) 1.25
The history of neuromyelitis optica. J Neuroinflammation (2013) 1.25
The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease. J Neuroimmunol (2005) 1.22
IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem (2003) 1.21
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler (2011) 1.19
Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer (2009) 1.18
Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis. PLoS One (2013) 1.18
Nucleosomal DNA fragments in autoimmune diseases. Ann N Y Acad Sci (2006) 1.16
GABAB receptor antibodies in paraneoplastic cerebellar ataxia. J Neuroimmunol (2013) 1.14
Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis. Neurosci Lett (2004) 1.12
Episodic breathlessness: a clinically relevant and rising issue. Ann Am Thorac Soc (2014) 1.08
Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum (2010) 1.06
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology (2004) 1.05
Standardizing integration of palliative care into comprehensive cancer therapy--a disease specific approach. Support Care Cancer (2011) 1.05
Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis. J Neuroimmunol (2009) 1.02
Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis. Ann Neurol (2011) 1.02
Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis. Blood (2007) 1.02
BAFF is elevated in serum of patients with Wegener's granulomatosis. J Autoimmun (2005) 1.02
Issues and needs in end-of-life decision making: an international modified Delphi study. Palliat Med (2011) 1.02
Removal of antibiotics in wastewater: Effect of hydraulic and solid retention times on the fate of tetracycline in the activated sludge process. Environ Sci Technol (2005) 1.01
Non-cancer patients in specialized palliative care in Germany: what are the problems? Palliat Med (2010) 1.00
B cells undergo unique compartmentalized redistribution in multiple sclerosis. J Autoimmun (2011) 0.99
Undergraduate training in palliative medicine in Germany: what effect does a curriculum without compulsory palliative care have on medical students' knowledge, skills and attitudes? Palliat Med (2007) 0.99
Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis. J Neurol (2009) 0.98
Neurofilament ELISA validation. J Immunol Methods (2009) 0.96
Ocular outcome and frequency of neurological manifestations in patients with acute posterior multifocal placoid pigment epitheliopathy (APMPPE). J Ophthalmic Inflamm Infect (2012) 0.96
Barriers and approaches to the successful integration of palliative care and oncology practice. J Natl Compr Canc Netw (2013) 0.95
Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. Brain (2004) 0.94
Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro. Neurosci Lett (2002) 0.94
A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization. J Neuroinflammation (2010) 0.94
CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. J Neuroimmunol (2003) 0.94
Recommending early integration of palliative care - does it work? Support Care Cancer (2011) 0.93
Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients. PLoS One (2011) 0.93
Undergraduate curricula in palliative medicine: a systematic analysis based on the palliative education assessment tool. J Palliat Med (2013) 0.93
Caspr2 antibodies in limbic encephalitis with cerebellar ataxia, dyskinesias and myoclonus. J Neurol Sci (2013) 0.92
Cancer Pain Management and Bone Metastases: An Update for the Clinician. Breast Care (Basel) (2012) 0.92
Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia. J Neuroinflammation (2013) 0.92
Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Clin Chem Lab Med (2010) 0.92
Unmet needs of severely affected multiple sclerosis patients: the health professionals' view. Palliat Med (2011) 0.91
Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals. J Neurol Sci (2006) 0.91
Ma2 antibodies: an evaluation of commercially available detection methods. Clin Lab (2011) 0.91
Intracerebral manifestation of an atypical monoclonal plasma cell hyperplasia depicted by MR perfusion and diffusion tensor imaging and MR spectroscopy. AJR Am J Roentgenol (2005) 0.90
Managing non-paraneoplastic Lambert-Eaton myasthenic syndrome: clinical characteristics in 25 German patients. J Neuroimmunol (2009) 0.90
Long term survival in anti-Hu associated adult neuroblastoma. J Neurol Sci (2009) 0.89
S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version. J Dtsch Dermatol Ges (2013) 0.88
The interleukin-7 receptor α chain contributes to altered homeostasis of regulatory T cells in multiple sclerosis. Eur J Immunol (2011) 0.88
Patients feeling severely affected by multiple sclerosis: how do patients want to communicate about end-of-life issues? Patient Educ Couns (2012) 0.88
Unmet needs of patients feeling severely affected by multiple sclerosis in Germany: a qualitative study. J Palliat Med (2014) 0.88
Palliative care for multiple sclerosis: a counter-intuitive approach? Mult Scler (2010) 0.88
The use of Grounded theory in palliative care: methodological challenges and strategies. J Palliat Med (2010) 0.87
Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel. J Neuroimmunol (2008) 0.86
Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism. Anticancer Res (2007) 0.86
Identifying patients suitable for palliative care--a descriptive analysis of enquiries using a Case Management Process Model approach. BMC Res Notes (2012) 0.86
Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activity. Clin Immunol (2009) 0.85
Fine-tuning of regulatory T cell function: the role of calcium signals and naive regulatory T cells for regulatory T cell deficiency in multiple sclerosis. J Immunol (2013) 0.85
Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study. J Neuroinflammation (2014) 0.85
Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection. J Neurol Sci (2008) 0.85
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis. PLoS One (2013) 0.85
Facilitating Early Integration of Palliative Care into Breast Cancer Therapy. Promoting Disease-Specific Guidelines. Breast Care (Basel) (2011) 0.84
Persistence of immunopathological and radiological traits in multiple sclerosis. Arch Neurol (2008) 0.84
Challenges in end-of-life communication. Curr Opin Support Palliat Care (2012) 0.84
Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate. J Neuroinflammation (2014) 0.83
Multiple sclerosis and palliative care - perceptions of severely affected multiple sclerosis patients and their health professionals: a qualitative study. BMC Palliat Care (2014) 0.83
Palliative care consultation service and palliative care unit: why do we need both? Oncologist (2012) 0.83
Measuring biomolecular binding events with a compact disc player device. Angew Chem Int Ed Engl (2005) 0.82
Visual evoked potentials in neuromyelitis optica and its spectrum disorders. Mult Scler (2013) 0.82
Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment. Environ Toxicol Chem (2005) 0.82
Implementing WHO recommendations for palliative care into routine lung cancer therapy: a feasibility project. J Palliat Med (2010) 0.82
Integrating Palliative Medicine into Comprehensive Breast Cancer Therapy - a Pilot Project. Breast Care (Basel) (2011) 0.82
Practicability, safety, and efficacy of a "German model" for opioid conversion to oral levo-methadone. Support Care Cancer (2011) 0.82
Disgust and fear recognition in paraneoplastic limbic encephalitis. Cortex (2009) 0.81